{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:27:38Z","timestamp":1787617658969,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>To evaluate four methods of injecting indocyanine green (ICG) around the adnexa and identify the optimal technique for ovarian sentinel lymph node (SLN) mapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHOD:<\/jats:title>\n                    <jats:p>Patients presenting for management of an adnexal mass were prospectively enrolled. Patients with peritoneal carcinomatosis were excluded. Four injection methods were evaluated: 1) intratubal, 2) paraovarian peritoneum, 3) infundibulopelvic (IP) ligament after resection of the adnexal mass, and 4) IP ligament before resection of the adnexal mass. Two mL of ICG was injected, and at least 10 minutes of transit time was allowed. The ipsilateral and contralateral pelvic and para-aortic lymph node beds were evaluated for ICG uptake. Retroperitoneal nodal resection was performed if indicated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>EXPERIENCE:<\/jats:title>\n                    <jats:p>Forty patients were enrolled, 10 in each group. For method 1, 20.0% of SLNs mapped, all to the ipsilateral para-aortic lymph node bed. For method 2, 10.0% mapped, only to the ipsilateral para-aortic lymph node bed. For method 3, 50.0% mapped to the ipsilateral para-aortic lymph node bed (n=3), contralateral para-aortic lymph node bed (n=1), or ipsilateral pelvic lymph node bed (n=1). For method 4, 70.0% mapped to the ipsilateral para-aortic lymph node bed (n=5) or ipsilateral pelvic lymph node bed (n=2). Surgeons reported methods 1 and 2 as cumbersome, and excessive peritoneal staining made SLN identification difficult. No injection-related complications were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Injection of ICG into the IP ligament before or after adnexal mass resection led to similar rates of SLN mapping and was deemed feasible by surgeons. Only one SLN was identified contralateral to the adnexal mass, and all but three mapped to the para-aortic region. Injection into the IP ligament should be evaluated in patients with likely adnexal malignancy, including SLN resection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006077","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T21:02:33Z","timestamp":1759438953000},"page":"769-774","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A Feasibility Study for Mapping Ovarian Sentinel Lymph Nodes"],"prefix":"10.1097","volume":"146","author":[{"given":"Olga T.","family":"Filippova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara C.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Tomberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Aviki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"R1-20260824","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13048-016-0265-4","article-title":"Lymphatic mapping and sentinel node biopsy in ovarian tumors: a study using intra-operative TC-99m-Phytate and lymphoscintigraphy imaging","volume":"9","author":"Hassanzadeh","year":"2016","journal-title":"J Ovarian Res"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/IGC.0000000000000514","article-title":"Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer","volume":"25","author":"Kleppe","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2967\/jnumed.114.144329","article-title":"The detection of sentinel nodes in ovarian cancer: a feasibility study","volume":"55","author":"Kleppe","year":"2014","journal-title":"J Nucl Med"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jmig.2016.09.006","article-title":"Near-infrared fluorescence-guided sentinel node mapping of the ovary with indocyanine green in a minimally invasive setting: a feasible study","volume":"24","author":"Buda","year":"2017","journal-title":"J Minimal Invasive Gynecol"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/IGC.0000000000000948","article-title":"Sentinel node and ovarian tumors: a series of 20 patients","volume":"27","author":"Nyberg","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.3390\/diagnostics13203209","article-title":"Feasibility of sentinel lymph node biopsy in early-stage epithelial ovarian cancer: a systematic review and meta-analysis","volume":"13","author":"Zachou","year":"2023","journal-title":"Diagnostics"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/ijgc-2020-001289","article-title":"Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial","volume":"30","author":"Lago","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2023.11.007","article-title":"Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial\u2014a further step towards lymphadenectomy replacement","volume":"179","author":"Agust\u00ed","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"113435","DOI":"10.1016\/j.ejca.2023.113435","article-title":"Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY)","volume":"196","author":"Nero","year":"2024","journal-title":"Eur J Cancer"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:11:38Z","timestamp":1787577098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006077"}},"subtitle":["A Memorial Sloan Kettering Cancer Center Team Ovary Study"],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006077","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"2025-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}